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cells with mucosal ulcerations occurs caused by enzymes 
and mediators mainly secreted by macrophages and 
granulocytes. Tissue repair has to take place involving 
new tissue formation and scar constitution  [3] . Usually, 
this tissue repair is a self-limiting process requiring a 
well-controlled balance between pro- and anti-inflam-
matory signals as well as a tightly regulated matrix for-
mation and degradation  [3] . According to this view, fi-
brosis is an overzealous healing response to inflamma-
tion-induced injury  [3] . It is still unclear what triggers 
increased fibrosis in some patients and not in others.
 In this issue of Digestion , Masaru Yamagata et al. [4] 
screened 1,115 patients with UC that presented at Kita-
sato University East Hospital from 1986 to 2009. Only 15 
cases of those 1,115 had a benign stricture of the colon. Of 
these 15 cases, 9 had to undergo surgery so that colonic 
tissue was available for analysis. In the stenotic areas, the 
authors describe a significant increase of b-FGF-positive 
inflammatory cells and myofibroblasts. Most b-FGF-
positive cells were also found to be positively stained for 
myeloperoxidase. The authors further describe an asso-
ciation between the number of b-FGF-positive cells and 
total neutrophil counts.
 This could indicate that neutrophils present in the in-
flamed mucosa of patients with UC in crypt abscesses or 
in the mucosa may activate mesenchymal cells via the se-
 Both inflammatory bowel diseases (IBD), namely ul-
cerative colitis (UC) and Crohn’s disease (CD), are associ-
ated with chronic tissue damage and continuous tissue 
repair. Fibrotic disease courses still resemble a clinical 
challenge. In UC, intestinal fibrosis is seen frequently af-
ter long disease courses; however, the fibrosis and scar 
formation is usually limited to the mucosa. A stricture 
formation is much rarer and only found in less than 5% 
of UC patients. Nevertheless, strictures occur and are 
sometimes localized in the rectum. In those cases, the 
clinical management is very difficult. Whereas CD is a 
transmural disease which may explain the activation of 
mesenchymal cells and the subsequent stricture forma-
tion originating from the muscularis layers, UC is limited 
to the mucosa. Therefore, stricture formation is much 
harder to understand and different mechanisms of stric-
ture may exist in CD and UC.
 It is generally accepted that intestinal myofibroblasts 
play a major role in the pathophysiology of fibrosis forma-
tion. During fibrosis formation resident mesenchymal 
cells transform into activated, matrix-depositing myofi-
broblasts  [1] . However, the underlying molecular mecha-
nisms causing this mesenchymal cell activation are not 
yet clear  [2] .
 Inflammation always causes damage to the tissue in 
which it occurs. In patients with UC, a loss of epithelial 
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cretion of b-FGF. Unfortunately, there are no reliable an-
imal models to test this hypothesis. Immunohistochem-
istry can be instructive; however, it is certainly no proof 
of a functional concept. In vitro studies also do not allow 
one to conclude on the in vivo situation. Therefore, this 
interesting concept cannot be challenged by respective 
disease models, which would be necessary to apply anti-
b-FGF strategies in a therapeutic approach.
 From this interesting study, it again becomes obvious 
what we need most in intestinal fibrosis research: similar 
to lung fibrosis or renal fibrosis we have to develop in vivo 
models for intestinal fibrosis in the near future to be able 
to bring new and interesting concepts on pathopysiology 
back to the bedside in clinical studies. Developing these 
models therefore is a rewarding service for all our pa-
tients suffering from stricturing IBD.
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